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Abstract: Chrysin is a natural flavonoid currently under investigation due to its important 
biological anti-cancer properties. In most of the cancer cells tested, chrysin has shown to 
inhibit proliferation and induce apoptosis, and is more potent than other tested flavonoids 
in leukemia cells, where chrysin is likely to act via activation of caspases and inactivation 
of Akt signaling in the cells. Moreover, structure-activity relationships have revealed that 
the chemical structure of chrysin meets the key structural requirements of flavonoids for 
potent cytotoxicity in leukemia cells. It is possible that combination therapy or modified 
chrysin could be more potent than single-agent use or administration of unmodified chrysin. 
This study may help to develop ways of improving the effectiveness of chrysin in the 
treatment of leukemia and other human cancers in vitro. 
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1. Introduction of Flavonoids 
Flavonoids are a broad class of plant pigments that are ubiquitously present in fruit- and vegetable-
derived foods [1,2]. Flavonoids can be easily ingested and a high level of flavonoids in food has been 
identified as an important constituent of the human diet. More than 4,000 types of biologically active 
flavonoids have been identified [3], which can be further divided into flavonols, flavones, flavanols, 
flavanones, anthocyanidins and isoflavonoid subclasses [4]. Chrysin, which is the focus of this review, 
is a flavone. The flavones have a common chemical structure, consisting of fused A and C rings, and a 
phenyl B ring attached to position 2 of the C ring (Figure 1A). Flavones, such as apigenin, baicalein, 
OPEN ACCESSInt. J. Mol. Sci. 2010, 11                 
 
 
2189
chrysin and scutellarein, were recently identified as having important biological roles in nitrogen 
fixation and chemical defenses [3-11].  
Figure 1. (A) Common chemical structure of flavones. Flavones have a common chemical 
structure consisting of fused A and C rings, and a phenyl B ring attached to position 2 of 
the C ring. (B) Chrysin is in the flavone subgroup of flavonoids and shares a common 
flavone structure with hydroxyls at position 5 and 7 of the A ring. Replacing the hydroxyl 
with a phosphate group at position 7, such as in diethyl chrysin-7-yl phosphate (CPE).  
(C) or at positions 5 and 7, such as in tetraethyl bis-phosphoric ester of chrysin (CP).  
(D), enhances the anti-cancer potential of the chrysin. 
(A) Common chemical structure of flavones 
 
 
(B) Chrysin  (C) CPE 
(D) CP 
 
 
Among the flavonoids studied, apigenin [5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one] 
has shown a remarkable inhibitory effect on cancer cell growth in both in vitro and in vivo tumor 
models [12,13]. Apigenin also possesses anti-inflammatory and free radical scavenging properties in 
several cancer cell lines [14,15], and inhibits tumor cell invasion, metastasis [16], mitogen-activated 
protein kinases (MAPKs) and its downstream oncogenes [17]. Chrysin (5,7-dihydroxy-2-phenyl-4H-
chromen-4-one) is an analog of apigenin [18,19], but its anti-cancer properties have rarely been 
studied. Chrysin shares the common flavone structure with additional hydroxyls at positions 5 and 7 of 
the A ring (Figure 1B). Chrysin has recently shown to be a potent inhibitor of aromatase [18] and of 
human immunodeficiency virus activation in models of latent infection [20]. It has also demonstrated  
anti-inflammatory [21] and anti-oxidant effects [22], and has shown cancer chemopreventive activity Int. J. Mol. Sci. 2010, 11                 
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via induction of apoptosis in diverse range of human and rat cell types. However, studies of the effects 
of chrysin on human cancers remain rare. 
Activation of apoptosis is the key molecular mechanism responsible for the anti-cancer activities of 
most of the currently studied potential anti-cancer agents, including chrysin. Apoptosis contrasts with 
cell necrosis, in which the cells suffer a major insult, resulting in loss of membrane integrity, swelling 
and disruption [23]. During necrosis, the cellular contents are uncontrollably released into the 
extracellular environment, causing damage to surrounding cells and a strong inflammatory response in 
the corresponding tissues. In contrast, apoptosis induces cell shrinkage, chromatin condensation and 
margination at the nuclear periphery, with the eventual formation of membrane-bound apoptotic 
bodies containing organelles, cytosol and nuclear fragments, which are then phagocytosed without 
triggering inflammatory processes in the surrounding tissues. Although the chemical structure of 
chrysin with only two hydroxyls at position 5 and 7 of A ring showed lower cytotoxicity activity in 
certain human cancer cells, the potential apoptotic effect of chrysin has been reported in human 
cervical cancer, leukemia, esophageal squamous carcinoma, malignant glioma, breast carcinoma, 
prostate cancer, non-small cell lung cancer (NSCLC) and colon cancer in vitro, as outlined in Table 1.  
Table 1. The apoptotic effects of chrysin in human cervical cancer, leukemia, esophageal 
squamous carcinoma, malignant glioma, breast carcinoma and prostate cancer in vitro.  
Cancer type  Reference
  Effect and molecular mechanism 
Cervical 
cancer 
[24] 
Chrysin (IC50  = 14.2 µM) inhibited proliferation and induced 
apoptosis in HeLa cells, though the effects were not as potent as 
those of its synthetic derivative compounds. 
[25] 
Chrysin (30 µM) potentially induced p38 and NFkappaB/p65 
activation in HeLa cells. 
Leukemia 
[26] 
Chrysin (IC50 = 16 μM) showed to be the most potent flavonoid to 
reduce cell viability and induce apoptotic DNA fragmentation in 
U937 cells. 
[27,28] 
Chrysin induced apoptosis in Bcl-2 overexpressing U937 leukemia 
cells, was associated with activation of caspase-3 and PLC-1 
degradation. The induction of apoptosis was accompanied by down-
regulation of XIAP and inactivation of Akt. 
[29] 
Chrysin had the ability to abolish SCF/c-Kit signaling by inhibiting 
the PI3K pathway in MO7e, myeloid leukemia cells. 
[30] 
Chrysin, alone or in combination with other compounds, decreased 
Akt phosphorylation and potentially caused mitochondrial 
dysfunction in THP-1 and HL-60 leukemia cells. 
Esophageal 
squamous 
carcinoma 
[31,32] 
 
Chrysin (IC50 = 63 M) induced cytotoxicity in KYSE-510 cells in 
dose- and time-dependent manners. 
Malignant 
glioma, breast 
carcinoma, 
prostate 
cancer 
[11] 
Chrysin (100 μM) showed dose-dependent inhibition of U87-MG, 
MDA-MB-231, U-251 and PC3 proliferation, and displayed 
apoptotic activity in U87-MG cells. However, the study did not 
report details about the apoptotic activity of chrysin in U-251, 
MDA-MB-231 and PC3 cells. Int. J. Mol. Sci. 2010, 11                 
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Table 1. Cont. 
Cancer type  Reference
  Effect and molecular mechanism 
NSCLC  [33] 
Chrysin and wogonin showed to have potential as adjuvant therapy 
for drug-resistant NSCLC, especially in patients with AKR1C1/1C2 
overexpression where IL-6-induced AKR1C1/1C2 overexpression 
and drug resistance could be inhibited by these flavonoids in H23 
cells. 
Colon cancer  [34] 
Chrysin caused the SW480 cells in cell-cycle arrest at the G2/M 
phase in a dose-dependent manner. 
 
2. Chrysin Inhibits Proliferation and Induces Apoptosis in HeLa Cells 
A study by Zhang et al. [24] demonstrated that chrysin and its derivatives   
[diethyl chrysin-7-yl phosphate (CPE: C19H19O7P) and tetraethyl bis-phosphoric ester of chrysin   
(CP: C23H28O10P2)] exhibited potential anti-cancer effects in human cervical carcinoma. The chemical 
structures showed that CPE and CP have phosphate groups at positions 5 and/or 7 of the A ring, 
respectively (Figure 1C and 1D), which replace the hydroxyls at positions 5 and/or 7 of the A ring in 
chrysin. According to this study, chrysin and phosphorylated chrysin effectively inhibited the growth 
of cervical cancer cells, HeLa, via apoptosis induction and down-regulated the proliferating cell 
nuclear antigen (PCNA) in the cells. However, how the chrysin improved the resistant of   
TRAIL-induced apoptosis in HeLa cells was not mentioned in this study. Another study showed that 
chrysin potentially induced p38, therefore activated NFkappaB/p65 in the HeLa cells [25]. The MAPK 
p38 pathway has been implicated in the regulation of a wide spectrum of cellular processes, including 
cell-cycle arrest and apoptosis. Besides, it has been regarded as a potential phosphate donor for the p65 
subunit of NFkappaB. According to the study [25], treatment of HeLa cells with 30 μM chrysin for  
24 h induced a significant increase of NFkappaB/p65 levels in the cells, as demonstrated by EMSA. 
The signals could be suppressed by a specific p38 or p65 inhibitor indicating that the p38 or p65 could 
be useful therapeutic targets of chrysin to control gene expression in HeLa cells. However, no 
correlation of pro-apoptotic or apoptotic activity induced by chrysin in this phenomenon was clearly 
stated in the study. Although, chrysin was found to significantly sensitize the TNFalpha-induced 
apoptosis in human colorectal cancer cell line HCT-116, human liver cancer cell line HepG2, and the 
human nasopharyngeal carcinoma cell line CNE-1, in which such sensitization is closely associated 
with inhibitory effect on NFkappaB activation, the phenomenon may occur differently in HeLa cells 
[35]. Therefore, the NFkappaB remains a potential target to study the mechanism of apoptosis induced 
by chrysin in HeLa cells. 
Although both chrysin and phosphorylated chrysin could inhibit proliferation and induced apoptosis 
in HeLa cells, as mentioned above, the effects of the phosphorylated chrysins were likely more potent 
than that of non-phosphorylated chrysin, where the estimated IC50 for chrysin was 14.2 µM, followed 
by CPE (IC50  = 10.3 µM) and CP (IC50  = 9.8 µM), assessed by the cell viability assays [24]. 
Phosphorylated chrysin(s), which could easily form non-covalent compound with lysozyme, are thus 
concluded as more effective in inhibiting cancer cell growth and inducing apoptosis than   
non-phosphorylated chrysin in HeLa cells.  Int. J. Mol. Sci. 2010, 11                 
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3. Chrysin Induces Apoptosis in Leukemia Cells 
In one study, 22 different flavonoids and related compounds were screened in human leukemia 
cells, U937. Among the flavonoids tested, genistein, apigenin, alpha-naphto-flavone, chrysin, 
quercetin, galangin, luteolin, fisetin and 3,7-dihydroxyflavone were found to significantly reduce the 
cellular viability of the U937 cells. However, only apigenin, chrysin, quercetin, galangin, luteolin and 
fisetin were found to clearly induce the oligonucleosomal DNA fragmentation at 50 M after 6 h of 
treatment [26]. Chrysin was the most effective flavonoid in terms of reducing the viability of the U937 
cells with an IC50 of 16 μM. Chrysin also potentiated the effects of TNFalpha in triggering apoptosis in 
the cells. On the other hand, Woo et al. [27] showed that chrysin induced apoptosis in association with 
activation of caspase-3, involving inactivation of Akt or Protein Kinases B (PKB) signaling and   
down-regulation of X-linked inhibitor of apoptosis protein (XIAP) in the U937 cells. This study 
provided the first evidence of a more detailed molecular mechanism whereby chrysin induces the 
apoptosis in leukemia cells namely via Akt dephosphorylation of the phosphoinositide 3 kinase (PI3K) 
signaling pathway. 
The Akt signaling pathway, from PI3K to phosphoinositide-dependent kinase-1 (PDK1) and from 
PDK1 to Akt, mediates apoptosis in human cancer cells (Figure 2). Activation of Akt via 
phosphorylation prevents apoptosis [36], whereas dephosphorylation is likely to initiate apoptosis. 
Phosphorylation of Akt phosphorylates BAD (Bcl-2-associated death protein) and a non-active form of 
caspase-9, which are the hosts of the cell-signaling proteins. Phosphorylated BAD binds to cytosolic 
14-3-3 proteins, resulting in a failure of the protein to heterodimerize with Bcl-2 at the mitochondrial 
membrane [37]. Dephosphorylation of BAD releases BAD from cytosolic 14-3-3 proteins, which 
subsequently form heterodimers with Bcl-2 family proteins and migrate into the mitochondrial 
membrane, where they induce the release of cytochrome c by altering the membrane pores [38,39]. 
Cytochrome c in the cytoplasm combines with Apaf-1 and caspase-9 to form a complex termed an 
apoptosome, in the presence of ATP, in order to activate the caspase-9 [39]. The caspase-9 
subsequently activates the downstream executor caspase-3. Activation of caspase-3 and the subsequent 
degradative events probably trigger apoptosis [39,40]. Conversely, phosphorylation of caspase-9 by 
phosphorylated Akt prevents formation of the apoptosome complex, and therefore the downstream 
event of apoptosis is inhibited. 
Woo et al. [27] noted several important effects of chrysin in U937 cells: (1) chrysin mediated the 
release of cytochrome c from mitochondria into the cytoplasm; (2) chrysin induced elevated caspase- 
3 activity and proteolytic cleavage of its downstream targets, such as phospholipase C-gamma-1   
(PLC-gamma1), which is correlated with down-regulation of XIAP; and (3) chrysin decreased 
phosphorylated Akt levels in cells where the PI3K pathway plays a role in regulating the mechanism. 
These results suggested that chrysin-induced apoptosis was likely to be caspase- and mitochondria-
dependent, and probably occurs via deregulation of PI3K/Akt, with involvement of XIAP. However, 
no measurement of BAD protein levels was reported in this study. The results of this study are in 
agreement with many other studies showing that chrysin, alone or in combination with other 
compounds, decreased the Akt phosphorylation and potentially resulted in mitochondrial dysfunction 
in leukemia cells [28,30]. Chrysin has also been reported to have the ability to abolish the stem cell 
factor (SCF)/c-Kit signaling by inhibiting the PI3K pathway [29]. In addition, Monasterio et al. [26] Int. J. Mol. Sci. 2010, 11                 
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reported that flavonoids, including chrysin, induced apoptosis via a mechanism that required the 
activation of caspase-3 and caspase-8, indicating that chrysin-induced apoptosis could act via a ligand 
receptor-dependent cell death mechanism. This study also suggested a relationship between Akt and 
NFkappaB signaling in the cells. However, more studies are warranted to further evaluate the 
relationship of Akt and NFkappaB in the chrysin-treated leukemia cells. 
Figure 2. The PI3K/Akt signaling pathway. Chrysin is likely to act via activation of 
caspases and inactivation of Akt signaling in leukemia cells. () depicts chrysin. 
 Int. J. Mol. Sci. 2010, 11                 
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A significant decrease in human telomerase reverse transcriptase (hTERT) expression levels was 
also observed in leukemia cells treated with 60 ng/mL Manisa propolis, owing to its constituent of 
chrysin [41]. Other studies, such as that of Josipovic and Orsolic [42], demonstrated that chrysin (as 
well as quercetin and caffeic acid) showed a high level of cytotoxicity in leukemia cells. The methanol 
extracts of apigenin, baicalein, chrysin, luteolin and wogonin have also shown a strong anti-leukemic 
activity [43]. All these studies indicated that chrysin exhibited potential anti-leukemic activities, 
suggesting its use as a potential anti-leukemic agent. The proliferation inhibitory effects of most of the 
flavonoids, including chrysin, in leukemia cells appear to be dose-dependent [44]. Moreover, 
structure-activity relationship studies reveal that the chemical structure of chrysin, which consists of a  
2,3-double bond of C ring, a B ring attached to C ring at position 2, appropriate hydroxyls at position 5 
and 7 of A ring, are likely to meet the key structural requirements of flavonoids for potent cytotoxicity 
in leukemia cells [26].  
4. Cytotoxicity of Chrysin in Esophageal Squamous Carcinoma 
The cytotoxic effects of structurally related flavones (luteolin, apigenin, chrysin) and flavonols 
(quercetin, kaempferol, myricetin), as well as the molecular mechanisms responsible for the cytotoxic 
effects in a human esophageal squamous cell carcinoma cell line, KYSE-510, have been determined by 
Zhang et al. [32]. The results of MTT assays showed that chrysin, as well as other flavonoids tested, 
were able to induce the cytotoxicity in KYSE-510 cells in dose- and time-dependent manners. Chrysin 
was estimated to have an IC50 of 63 M in the cell line. Flow cytometry and DNA fragmentation 
analyses indicated that the cytotoxicity induced by chrysin (80 µM) and other flavonoids for 24 h was 
mediated by G(2)/M cell cycle arrest and apoptosis. Furthermore, the study revealed that treatment of 
KYSE-510 cells with chrysin (and other flavonoids) caused G(2)/M arrest through up-regulation of 
p21(waf1) and down-regulation of cyclin B1 at the mRNA and protein levels. In addition, the 
induction of apoptosis was p53-independent, but mitochondria-mediated through an up-regulation of  
p53-inducible gene 3 (PIG3) and cleavage of caspase-9 and caspase-3. The results of western blot 
analysis further showed that the increases in p63 and p73 translation or stability might contribute to the 
regulation of p21(waf1), cyclin B1 and PIG3 in the chrysin-induced KYSE-510 cells. 
5. Chrysin in Malignant Glioma, Breast Carcinoma, Prostate and Other Human Cancers 
In a study by Parajuli et al. [11], chrysin exhibited tumor-specific effects in diverse range of human 
cell lines, including malignant glioma cells (U87-MG and U-251), breast carcinoma cells (MDA-MB-
231) and prostate cancer cells (PC3). Chrysin and other flavonoids (apigenin, baicalein, baicalin, 
scutellarein and wogonin) extracted from Scutellaria plants, showed dose-dependent inhibition of 
U87-MG proliferation. Apigenin was the most potent flavonoid, with IC30, IC50 and IC70 of 
approximately 16 μM, 62 μM and 250 μM, respectively, compared to IC30, IC50 and IC70 for chrysin of 
approximately 40 μM, 100 μM and 200 μM, respectively. This study also found that all six flavonoids, 
including chrysin (100 μM), significantly inhibited the proliferation of MDA-MB-231 cells, where a 
significant 43% inhibition was observed following treatment with chrysin. Chrysin also significantly 
inhibited the proliferation of U-251 and PC3 cells at 100 μM concentrations. All flavonoids examined, 
except scutellarein, also displayed significantly higher apoptotic activity in U87-MG cells compared to Int. J. Mol. Sci. 2010, 11                 
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untreated U87-MG cells. The induction of apoptosis was significantly enhanced by increasing the dose 
of flavonoids, and further enhanced by prolonging treatment time from 72 h to 96 h. In this case, 
baicalein and baicalin produced the highest levels of apoptosis in U87-MG cells, followed by wogonin, 
apigenin, chrysin and scutellarein (not statistically significant), in accordance. However, the study did 
not report any details regarding the apoptotic activity of chrysin and other flavonoids in U-251,   
MDA-MB-231 and PC3 cells. 
Other studies have reported the effects of chrysin, including in NSCLC and colon carcinoma. For 
example, chrysin (and wogonin), have been reported to have potential as adjuvant therapy for   
drug-resistant NSCLC, especially in patients with AKR1C1/1C2 overexpression [33]. This study 
evaluated the effect of flavonoids and demonstrated that IL-6-induced AKR1C1/1C2 overexpression 
and drug resistance can be inhibited by chrysin and wogonin, which both demonstrated multiple anti-
inflammatory effects in these cells. Chrysin has also been demonstrated to cause SW480 cells to arrest 
at the G2/M phase of the cell-cycle in a dose-dependent manner [34]. Combining chrysin with 
apigenin was found to double the proportion of SW480 cells in G2/M. Thus, apigenin-related 
flavonoids such as chrysin, may cooperatively protect against colorectal cancer through conjoint 
blocking of cell-cycle progression. Chrysin also inhibited the lipopolysaccharide-induced COX-2 
expression via inhibition of nuclear factor IL-6 (NF-IL6) [45]. Thus, chrysin might also improve the 
drug sensitivity of cancer cells by modulating the signaling pathways of inflammatory cytokines.  
Perhaps the biological activities of chrysin could be improved by combination with other flavonoids, 
as combinations of flavonoids have been demonstrated to have better apoptotic effects than individual 
use of chrysin. For example, the combination of chrysin with apigenin, baicalin and scutellarein (5 μM 
each) inhibited the proliferation of U87-MG glioma cells by almost 50%, while chrysin alone showed 
no anti-proliferative activity in these cells [11].  
Besides, modified chrysin is demonstrated to exhibit more potent anti-cancer effects than the 
unmodified chrysin. In addition to the inhibitory effects of phosphorylated chrysin in HeLa cells, as 
mentioned above, 5-allyl-7-gen-difluoromethylenechrysin (ADFMChR) has shown to inhibit the 
proliferation of human ovarian cancer cells, CoC1, in a dose-dependent manner (IC50 of 7.76 µmol/L) 
[46]. The ADFMChR significantly induced apoptosis in this cell line in a concentration-dependent 
manner, with rates of apoptosis of 33.07% and 73.70% after the cells were treated with 10.0 and  
30.0 µmol/L of ADFMChR, respectively, for 48 h. The apoptosis rate was compared with the cells 
treated with 10.0 and 30.0 µmol/L of unmodified chrysin, which rates the apoptosis of 21.70% and 
40.00%, respectively. Moreover, another study investigating the effects of 5,7-dihydroxy-8-
nitrochrysin (NOChR) on apoptosis in human gastric carcinoma cell line, SGC-7901, showed that 
NOChR markedly inhibited the proliferation of SGC-7901 cells in a dose-dependent manner, where 
the potency of NOChR (IC50 of 4.14 μmol/L) was 10 times higher than that of unmodified chrysin  
(IC50 of 40.56-μmol/L) [47]. Overall, all these studies suggest that modified chrysin could exhibit 
more potent anti-cancer effects than the unmodified chrysin.  
It is also possible that the potency of chrysin is improved by addition of more hydroxyl 
constituents. According to Monasterio et al. [26], at least two hydroxyls at positions 3, 5 or 7 of the A 
ring were needed to confer the pro-apoptotic activity. This phenomenon can be seen in   
4’,7-dihydroxyflavone, chrysin and galangin where the 4’,7-dihydroxyflavone has only one hydroxyl 
at position 7 of the A ring did not show pro-apoptotic activity, whereas the chrysin (which has two Int. J. Mol. Sci. 2010, 11                 
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hydroxyls at positions 5 and 7 of the A ring) and galangin (which has three hydroxyls at positions 3, 5 
and 7 of the A ring) have higher pro-apoptotic activity, in accordance. Moreover, the hydroxyls at 3' 
and/or 4' positions of the B ring are to increase the pro-apoptotic activity of the flavanoids, according 
to the study. However, the number of hydroxyl constituents in the B ring is not a good marker of the 
potential pro-apoptotic activity. Flavanoids that are not hydroxylated in the B ring, such as chrysin and 
galangin, are potent inducers of apoptosis. Introduction of hydroxyls may also lead to disturbance of 
the structure of flavanoids. 
6. Conclusions 
Chrysin inhibits proliferation and induces apoptosis in most cancer cells tested, and is likely more 
potent than other flavonoids in leukemia cells. Studies of the mechanism of action suggest that the 
chrysin is likely to act via caspase activation and inactivation of the Akt signaling. The biological 
activities of chrysin, perhaps, may be improved by combination with other flavonoids and 
modifications to the structure of chrysin. Although most studies support the conclusion that chrysin 
induces apoptosis in various tumor cell lines, the mechanism of induction of apoptosis remains 
unclear. Studies published so far are often haphazard and sometimes contradictory. Therefore, more 
studies are warranted to identify the potential molecule target of chrysin involved in the modulation of 
apoptosis in human cancer in vitro. 
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